Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli vaccine after results failed to demonstrate sufficient efficacy.

House Speaker Mike Johnson formally unveiled plans on Saturday for a government funding stopgap through September 30 — a measure intended to stave off a potential March 14 shutdown and buy time ...